Future Fund takes 6.5% stake in Attomarker Limited
Published
Future Fund has joined the register of Attomarker, a nanophotonic diagnostics firm, with a 6.5% ordinary-share stake.
Arden Capital SSAS also entered the register with a 0.9% ordinary-share stake.
Oxbridge Capital Limited joined with a 0.1% ordinary-share stake.
The filing also records share-count increases for British Innovation Fund, Mill Trust International Group (Singapore) Pte. Ltd and Bryn-y-Mor Holdings Ltd, suggesting fresh funding. It was filed on 24 August 2026, covering changes from 9 August 2025 to 9 August 2026.
Shareholder data
Source: Companies House confirmation statement (CS01) — period to , filed .
Changes in this confirmation statement
| Type | Shareholder | Shares | Change | Share classes |
|---|---|---|---|---|
| New shareholder | FUTURE FUND | 517 | — | ORDINARY 517 |
| New shareholder | ARDEN CAPITAL SSAS | 71 | — | ORDINARY 71 |
| New shareholder | OXBRIDGE CAPITAL LIMITED | 10 | — | ORDINARY 10 |
| Increased | MILL TRUST INTERNATIONAL GROUP (SINGAPORE) PTE. LTD | 39 | +875% | ORDINARY 39 |
Current shareholders (10)
| Shareholder | Total shares | Share classes |
|---|---|---|
| BRITISH INNOVATION FUND | 1,698 | ORDINARY 1,698 |
| UNIVERSITY OF EXETER | 1,210 | ORDINARY 765 DEFERRED 445 |
| FUTURE FUND | 517 | ORDINARY 517 |
| INNOVA MEDICAL GROUP INC. | 344 | ORDINARY 344 |
| ARDEN CAPITAL SSAS | 71 | ORDINARY 71 |
| BRYN-Y-MOR HOLDINGS LTD | 70 | ORDINARY 70 |
| MILLTRUST VENTURES VCC - FUTURE HEALTH FUND | 64 | ORDINARY 64 |
| FOUR PURSUITS VENTURES PRIVATE LIMITED | 53 | ORDINARY 53 |
| MILL TRUST INTERNATIONAL GROUP (SINGAPORE) PTE. LTD | 39 | ORDINARY 39 |
| OXBRIDGE CAPITAL LIMITED | 10 | ORDINARY 10 |
Contact the editorial team at editorial@fundingspotter.com